Antiinflammatory derivatives of 3-aryl-2,1-benzisoxazole
申请人:A.H. ROBINS COMPANY, INCORPORATED
公开号:EP0260924A1
公开(公告)日:1988-03-23
Novel 3-Aryl-2,1-benzisoxazole compounds having the formula:
wherein each R1 and R2 represents a hydrogen atom or methyl group;
R3 and R4 represent a hydroxyl, loweralkoxy, amino or -OM group wherein M is a pharmaceutically acceptable cation;
X represents a hydrogen or halogen atom, a loweralkyl or nitro group;
Y represents a hydrogen or halogen atom, a loweralkyl, loweralkoxy, nitro or trifluoromethyl group;
n and p are independently zero or one with the proviso that either n or p must be one
are disclosed. which have anti-inflammatory activity. Novel intermediates in the preparation of such compounds are also disclosed.
本发明公开了具有以下式子的新型 3-芳基-2,1-苯并异噁唑化合物: 其中每个 R1 和 R2 代表氢原子或甲基;R3 和 R4 代表羟基、低级烷氧基、氨基或 -OM 基团,其中 M 是药学上可接受的阳离子;X 代表氢原子或卤素原子、低级烷基或硝基;Y 代表氢原子或卤素原子、低级烷基、低级烷氧基、硝基或三氟甲基;n 和 p 独立地为 0 或 1,但 n 或 p 必须为 1。 本发明还公开了制备此类化合物的新型中间体。
Quinolinones as inhibitors of translation initiation complex
申请人:Sanford Burnham Prebys Medical Discovery Institute
公开号:US10577349B2
公开(公告)日:2020-03-03
Provided herein are compounds and pharmaceutical compositions comprising quinolinones. The quinolinones and compositions thereof are useful as eukaryotic translation initiation factor 4F (eIF4F) complex modulators.
Quinolinones as Inhibitors of Translation Initiation Complex
申请人:Sanford-Burnham Medical Research Institute
公开号:US20180044324A1
公开(公告)日:2018-02-15
Provided herein are compounds and pharmaceutical compositions comprising quinolinones. The quinolinones and compositions thereof are useful as eukaryotic translation initiation factor 4F (eIF4F) complex modulators.